Detalhe da pesquisa
1.
Endpoint adjudication in cardiovascular clinical trials.
Eur Heart J
; 44(46): 4835-4846, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935635
2.
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
Am Heart J
; 190: 113-122, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760204
3.
Implications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction.
ESC Heart Fail
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757437
4.
Learning from recent trials and shaping the future of acute heart failure trials.
Am Heart J
; 166(4): 629-35, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24093841
5.
Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis.
ESC Heart Fail
; 8(1): 662-669, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300277
6.
Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.
ESC Heart Fail
; 7(1): 274-278, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747132
7.
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure.
Am Heart J
; 158(6): 965-71, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19958863
8.
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease).
Am J Cardiol
; 119(11): 1703-1709, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28395884